Compare Novartis AG (NVS) vs Vanguard S&P 500 ETF (VOO) Price & Performance

Novartis AGTrade

Vanguard S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Vanguard S&P 500 ETF — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vanguard S&P 500 ETF trades at $687.73. The key difference: Novartis AG pays a 3.17% dividend while Vanguard S&P 500 ETF pays none, and Vanguard S&P 500 ETF is trading nearer its 52-week high, Novartis AG nearer its low. Which is the better fit depends on your goals.

	NVS	VOO
Market Cap	$290.25B	—
Sector	Health	Broad Market / Factor
52-Week High	$168.62	$698.29
52-Week Low	$113.50	$571.45
Enterprise Value	$330.27B	—
Dividend Yield	3.17%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 23 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

VOO

DIA ETF underperforms S&P 500 ETFs due to higher fees and price-weighted index design.24/7 Wall Street · 3 days agoBearish SPY ETF charges higher fees than its cheaper sibling SPYM with identical S&P 500 exposure.24/7 Wall Street · 4 days agoBearish S&P 500 falls 1.6% for the week, dipping below its 50-day moving average amid ongoing market volatility.ETF Trends · 4 days agoBearish View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.